FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

146411000001106: Periactin 4mg tablets (Merck Sharp & Dohme Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17122501000001110 Periactin 4mg tablets (Merck Sharp & Dohme Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
100804201000001116 Periactin 4mg tablets (Teva UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Periactin 4mg tablets (Merck Sharp & Dohme Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Periactin 4mg tablets (Merck Sharp & Dohme Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Periactin 4mg tablets (Merck Sharp & Dohme Ltd) Is a Product containing precisely cyproheptadine hydrochloride 4 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Periactin 4mg tablets (Merck Sharp & Dohme Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Periactin 4mg tablets (Merck Sharp & Dohme Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Periactin 4mg tablets (Merck Sharp & Dohme Ltd) Has active ingredient Cyproheptadine hydrochloride false Inferred relationship Existential restriction modifier
Periactin 4mg tablets (Merck Sharp & Dohme Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Periactin 4mg tablets (Merck Sharp & Dohme Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Periactin 4mg tablets (Merck Sharp & Dohme Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Periactin 4mg tablets (Merck Sharp & Dohme Ltd) Is a Periactin true Inferred relationship Existential restriction modifier
Periactin 4mg tablets (Merck Sharp & Dohme Ltd) Has specific active ingredient Cyproheptadine hydrochloride true Inferred relationship Existential restriction modifier
Periactin 4mg tablets (Merck Sharp & Dohme Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Periactin 4mg tablets (Merck Sharp & Dohme Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Periactin 4mg tablets (Merck Sharp & Dohme Ltd) 30 tablet 3 x 10 tablets Is pack of False Periactin 4mg tablets (Merck Sharp & Dohme Ltd) Inferred relationship Existential restriction modifier
Periactin 4mg tablets (Merck Sharp & Dohme Ltd) 30 tablet 3 x 10 tablets Has AMP True Periactin 4mg tablets (Merck Sharp & Dohme Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start